Herbert R.
Herbert R. Henney, Iii, Clarksboro, NJ US
Patent application number | Description | Published |
---|---|---|
20130030025 | USE OF POTASSIUM CHANNEL BLOCKERS TO TREAT CEREBRAL PALSY - Disclosed herein is the use of aminopyridines, such as 3-aminopyridine, 4-aminopyridine or 3,4-diaminopyridine, in the management and treatment of cerebral palsy patients of all ages. | 01-31-2013 |
Herbert R. Jones, Williston, VT US
Patent application number | Description | Published |
---|---|---|
20090030646 | AC magnetic tracking system with phase locking - Plural transmitter coils of a magnetic locating system are driven with widely-separated main frequencies. One of the transmitter coils is also driven with a marker frequency close to the main frequency applied to that coil. The receiver determines a phase relationship with the transmitter based on the main and marker frequencies, so that the receiver does not suffer from phase ambiguity. The main and marker frequencies may interfere with one another, and the receiver may correct for such interference based on known characteristics of the signals at the main and marker frequencies. | 01-29-2009 |
Herbert R. Kaewert, Atherton, CA US
Patent application number | Description | Published |
---|---|---|
20140340024 | DYNAMIC BOOST BATTERY CHARGERS - There is disclosed a dynamic boost charging system having a monitoring component configured to measure total DC current and/or battery current and a reporting component configured to transmit output data of the total DC current and/or battery current measured. A battery charger control system in operable connection with the monitoring component receives the data of the total DC current and/or battery current measured by the monitoring component, and is configured to: obtain an initial time and/or charge measurement; determine a time and/or charge to complete a recharge cycle based on the time and/or charge measurement; selectively use at least two preset DC output voltage settings, one of the at least two preset DC voltage settings being a float voltage, and another of the at least two preset DC voltage settings being a boost voltage; and maintain the boost voltage until the time has passed the charge has been provided. | 11-20-2014 |
Herbert R. Pinnick, Jr., Bartlesville, OK US
Patent application number | Description | Published |
---|---|---|
20150219615 | QUANTITATION OF NAPHTHENIC ACIDS IN WATER AND CRUDE OIL - The present disclosure relates generally to processes for accurate quantitation of naphthenic acids in liquid samples. The method allows efficient identification as well as quantitation of NA species based on carbon number and ring structure, but requires no chemical modification or extraction of the sample allowing a rapid throughput. Reverse phase liquid chromatographic separation of the sample minimizes (or eliminates) matrix suppression effects to allow detection of all NAs present in various samples by mass spectroscopy with superior detection thresholds that are as much as 350-fold lower than conventional methods. | 08-06-2015 |
20150219616 | SYSTEMS FOR QUANTITATION OF NAPHTHENIC ACIDS IN WATER AND CRUDE OIL - The present disclosure relates generally to systems for accurate quantitation of naphthenic acids in liquid samples. The system allows efficient identification as well as quantitation of NA species based on carbon number and ring structure, but requires no chemical modification or extraction of the sample allowing a rapid throughput. Reverse phase liquid chromatographic separation of the sample minimizes (or eliminates) matrix suppression effects to allow detection of all NAs present in various samples by mass spectroscopy with superior detection thresholds that are as much as 350-fold lower than conventional systems. | 08-06-2015 |
Herbert R. Radisch, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080274470 | NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER - The present invention provides a non-invasive method of obtaining a sample of endometrial cells for use in the diagnosis of endometrial cancer, as well as methods and kits for diagnosing, determining the prognosis of, and monitoring endometrial cancer. | 11-06-2008 |
20140277184 | IMPLANTABLE MEDICAL DEVICES COMPRISING BIODEGRADABLE ALLOYS - The invention provides medical devices comprising high-strength alloys which degrade over time in the body of a human or animal, at controlled degradation rates, without generating emboli. In one embodiment the alloy is formed into a bone fixation device such as an anchor, screw, plate, support or rod. In another embodiment the alloy is formed into a tissue fastening device such as staple. In yet another embodiment, the alloy is formed into a dental implant or a stent. | 09-18-2014 |
Herbert R. Radisch, Jr., San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090281490 | Traction Balloon - Balloon catheters and methods of making and using the same. A balloon catheter may include a catheter shaft and a balloon coupled thereto. A traction member may be coupled to the balloon catheter adjacent the balloon and may extend along a portion or all of the length of the balloon. The traction member can improve traction between the balloon and a target site. | 11-12-2009 |
20100174367 | IMPLANTABLE MEDICAL DEVICES COMPRISING BIO-DEGRADABLE ALLOYS - The invention provides medical devices comprising high-strength alloys which degrade over time in the body of a human or animal, at controlled degradation rates, without generating emboli. In one embodiment the alloy is formed into a bone fixation device such as an anchor, screw, plate, support or rod. In another embodiment the alloy is formed into a tissue fastening device such as staple. In yet another embodiment, the alloy is formed into a dental implant or a stent. | 07-08-2010 |
20120004718 | Platinum Enhanced Alloy and Intravascular or Implantable Medical Devices Manufactured Therefrom - A platinum enhanced radiopaque alloy particularly suitable for manufacture of implantable and/or intravascular medical devices. A stent is one preferred medical device which is a generally tubular structure that is expandable upon implantation in a vessel lumen to maintain flow therethrough. The stent is formed from the alloy which has improved radiopacity relative to present utilized stainless steel alloys. This alloy preferably contains from about 2 wt. % to about 50 wt. % platinum; from about 11 wt. % to about 18 wt. % chromium; about 5 wt. % to about 12 wt. % nickel and at least about 15 wt. % iron. | 01-05-2012 |
20120279881 | IMPLANTABLE MEDICAL DEVICES COMPRISING BIO-DEGRADABLE ALLOYS - The invention provides medical devices comprising high-strength alloys which degrade over time in the body of a human or animal, at controlled degradation rates, without generating emboli. In one embodiment the alloy is formed into a bone fixation device such as an anchor, screw, plate, support or rod. In another embodiment the alloy is formed into a tissue fastening device such as staple. In yet another embodiment, the alloy is formed into a dental implant or a stent. | 11-08-2012 |